How Trenbolone Affects Prolactin
Trenbolone elevates prolactin through progestogenic activity at pituitary lactotroph cells. Elevated prolactin can independently suppress LH, worsen gynecomastia risk, and impair sexual function, making it a critical marker to monitor during and after trenbolone use.
The Mechanism
Trenbolone and its metabolites bind progesterone receptors in pituitary lactotroph cells with significant affinity. Progesterone receptor activation in lactotrophs stimulates prolactin synthesis and secretion. This is independent of the dopaminergic pathway that normally regulates basal prolactin levels, which is why standard dopamine-mediated prolactin control may be overwhelmed during trenbolone use. Elevated prolactin in turn suppresses GnRH pulsatility and LH secretion at the hypothalamic-pituitary level, adding another layer of HPG axis suppression beyond trenbolone's direct androgenic effects.
Expected Changes
Prolactin may rise to 20-40 ng/mL or higher during trenbolone use (normal male range: 2-18 ng/mL). The elevation is dose-dependent and may persist for 2-4 weeks after the last trenbolone acetate injection (half-life approximately 3 days). Higher doses and longer cycles produce more pronounced prolactin elevation. Some individuals are more susceptible to progestin-driven prolactin elevation than others.
Monitoring Guidance
Check prolactin at baseline before starting trenbolone, at mid-cycle (4-6 weeks in), and at the start of PCT. If prolactin remains above 20 ng/mL at the mid-PCT blood draw (after trenbolone has cleared), this may be impairing LH recovery and requires intervention. Recheck prolactin at the post-PCT confirmation draw.
Management Strategies
Cabergoline 0.25-0.5 mg twice weekly is the standard treatment for trenbolone-induced hyperprolactinemia. Start cabergoline if prolactin exceeds 20 ng/mL with symptoms (sexual dysfunction, gynecomastia, low mood) or if it remains elevated during PCT and may be impairing recovery. Avoid overtreatment: prolactin below 2 ng/mL from excessive cabergoline can cause impulse control issues. Taper cabergoline once prolactin normalizes. If prolactin remains elevated 6-8 weeks after the last trenbolone dose and cabergoline fails to normalize it, investigate for prolactinoma (rare but important to exclude).
Further reading: Trenbolone bloodwork: 8 markers to monitor and the red lines to stop
Clinical Significance
Trenbolone-induced prolactin elevation is one of the most impactful secondary effects of 19-nor compounds, capable of independently impairing PCT recovery even after trenbolone itself has cleared.
Frequently Asked Questions
Related Articles
Starting TRT in Australia: Your Complete Guide
Complete guide to TRT in Australia. Testosterone levels by age, clinic options, injection protocols, fertility risks, and blood test monitoring.
Does Primobolan Lower Estrogen? What Users' Bloodwork Shows
Primo can't aromatize, but forums swear it lowers E2. What real user bloodwork shows, what the science says, and how to read your own labs on test and primo.
How to Fix Crashed E2 on TRT or Cycle (Symptoms and Labs)
Crashed E2 symptoms, the numbers that actually define low estradiol in men, which lab test to trust, and how long recovery takes after each AI.
TRT Does Not Cause Heart Attacks (But Blasting Is Different)
TRAVERSE cleared replacement-dose testosterone for CV risk. It says nothing about bodybuilder doses. The honest line is on your bloodwork, not your syringe.
Related Pages
See how this interaction affects your blood work
Upload your blood tests and log your compounds to see personalised interaction data overlaid on your marker trends.
Quick Facts
Effect Direction
Severity
Dose-Dependent
Reversible